Archive

Latest KFF Health News Stories

KHN’s ‘What the Health?’: Here Comes Reconciliation

KFF Health News Original

Democrats in Congress reached a tentative agreement to press ahead on a partisan bill that would dramatically expand health benefits for people on Medicare, those who buy their own insurance and individuals who have been shut out of coverage in states that didn’t expand Medicaid. Meanwhile, controversy continues to rage over whether vaccinated Americans will need a booster to protect against covid-19 variants, and who will pay for a new drug to treat Alzheimer’s disease. Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Rae Ellen Bichell, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a mother and daughter who fought an enormous emergency room bill.

How ERs Fail Patients With Addiction: One Patient’s Tragic Death

KFF Health News Original

Two intractable failings of the U.S. health care system — addiction treatment and medical costs — come to a head in the ER, where patients desperate for addiction treatment arrive, only to find the facility may not be equipped to deal with substance use or, if they are, treatment is prohibitively expensive.

Influx of Medical School Students Could Overwhelm Montana Resources, Program Leaders Warn

KFF Health News Original

Leaders of a regional medical school program in Montana say two proposed medical schools could create a flood of students they worry will strain the clinical faculty and resources in the state they use for training.

Senate Democrats’ Plan Boosts Spending on Medicare, ACA Subsidies, Long-Term Care

KFF Health News Original

The plan from high-wire negotiations would affect five key areas of health, but there will be further tense negotiations among Democratic lawmakers about specifics of the $3.5 trillion in funding. And all Senate Democrats will need to be behind the plan, because Republicans oppose it.

Dying Patients With Rare Diseases Struggle to Get Experimental Therapies

KFF Health News Original

When patients with common terminal illnesses such as cancer seek permission for compassionate use of therapies in the testing stage, their requests often are approved. But those with more unusual illnesses say drug companies are rarely willing to provide access.

Red State, Blue State, Twin Outbreak: Behind Wyoming and Colorado’s Anomalous Covid Spikes

KFF Health News Original

Statistics show that Colorado residents are much more likely than Wyoming residents to be vaccinated against covid. Yet both Wyoming and Colorado were among the top 12 states with the highest covid case rates at the beginning of July. A closer look at a pair of similarly sized counties in those states helps explain why.

KHN’s ‘What the Health?’: Becerra Urges Congress to Expand Medicare, Address Rx Prices

KFF Health News Original

Health and Human Services Secretary Xavier Becerra is the special guest for this bonus episode of KHN’s “What the Health?” podcast. He and host Julie Rovner discuss a breadth of topics the secretary oversees, including covid-19, prescription drug prices, Medicare, Medicaid and the Affordable Care Act.

As Congress Wrestles With Plans to Expand Medicare, Becerra Says Any One Will Do

KFF Health News Original

In an interview for KHN’s “What the Health?” podcast, HHS Secretary Xavier Becerra says the administration is eager for Congress to make changes to Medicare that will provide more benefits and make more older adults eligible for the program. He also said a priority will be making permanent the enhanced premium subsidies for Affordable Care Act marketplace plans.

Adolescentes voluntarios se abren paso como futuros profesionales en hogares de adultos mayores

KFF Health News Original

Desde que se puso en marcha en 2006, el programa de desarrollo para la carrera en geriatría ha ayudado a más de 700 estudiantes de secundaria de 10 escuelas de bajos recursos, en la ciudad de Nueva York, a adquirir experiencia práctica en cuidados geriátricos.

Teen Volunteers Get a Foot in the Door for Nursing Home Careers

KFF Health News Original

A group of New York senior living facilities offer teens from 10 underserved schools the chance to volunteer and get free training for entry-level health jobs, career coaching and assistance on college prep.

California Takes a Nibble at Offering Food Stamps to Undocumented Immigrants

KFF Health News Original

Food insecurity soared during the pandemic, including among unauthorized immigrants, who are not eligible for federally funded food stamps. California’s Democratic lawmakers want to expand the benefit to that population, but opponents cite the massive ongoing cost to the state.

Biden Is Caught in the Middle of Polarizing Abortion Politics

KFF Health News Original

The president, one of the last of a disappearing group of politicians who sought moderate compromises on abortion policy, is frustrating supporters. They wanted faster changes in federal rules. But abortion opponents — including Catholic bishops— are also taking him to task.

Doctores explican pros y contras de recetar la nueva droga para el Alzheimer

KFF Health News Original

Mientras médicos y expertos en políticas de salud debaten los méritos de Aduhelm, el primer fármaco para el Alzheimer aprobado en 18 años, los pacientes simplemente quieren saber: “¿me ayudará?”.

Federal Speech Rulings May Embolden Health Care Workers to Call Out Safety Issues

KFF Health News Original

Policies mandating company approval before talking publicly about conditions in hospitals have been a source of conflict over the past year, as physicians, nurses and other health workers have been disciplined for speaking or posting about what they view as dangerous covid-19 safety precautions. The appeals court’s decision could mean that hospitals — and other employers — will need to revise their policies.

Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug

KFF Health News Original

The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.